Yahoo Finance report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Why MPT Stock dropped -7.34% Today — RQD Quant Desk Flash
Medical Properties Trust Inc. (MPT) carries a Roarable Rating of D- (Sell) with 39/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Medical Properties Trust Inc. (NYSE: MPT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $2.02 (-7.34% 1D, market cap $1.30B). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, MPT ranks #922 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MPT compare to UMH and ALX in the Financials sector?
▼
Within the Financials sector (Real Estate Investment Trusts), MPT carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -6.0%. By comparison, UMH (UMH Properties Inc.) holds a D grade (49/100 RQD, P/E N/A, ROIC 0.7%, cap $1.30B) and ALX (Alexander's Inc.) posts a C grade (64/100 RQD, P/E 45.1x, ROIC 25.9%, cap $1.28B). Among the 5-stock peer group, ALX leads on earnings multiple (45.1x) while ALX leads on capital efficiency (25.9% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MPT?
▼
Per MPT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001287865), Medical Properties Trust Inc. generated $972.0M in revenue (-2.4% YoY), -$277.0M in net income, and $230.8M in free cash flow against $15.00B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
SEC Form 4 / 13F Thermometer: 45% Net Buy • Disciplined Float (-0.40% YoY Shares)
Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)
⚔️ Adversarial Opposing Case: What Could Spark a MPT Turnaround Squeeze
While MPT currently carries a cautious 39/100 (D-) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Financials with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.31) and Max Pain ($2.12) forces dealer call-delta covering toward $6.79.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why MPT Stock dropped -7.34% Today — RQD Quant Desk Flash
Medical Properties Trust Inc. (MPT) dropped -7.34% to $2.02, trading at 2% of its 52-week range ($2.06 – $6.47). Stretched risk/reward at current multiples (-6% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($2.06 – $6.47) with RSI-14 at 25.1 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.02 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 52% gross margin and $230.8M annual free cash flow.
Seeking Alpha report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Investing.com report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Quiver Quantitative report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
We're at the halfway point of another surprisingly strong REIT earnings season. Click here to read more on the REITs report.
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MPT)
- ✓Walkthrough of MPT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
MPT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -2.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MPT today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MPT. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MPT)
1. Head-to-Head Financials Peer Comparison (MPT vs. UMH, ALX, AAT, UNIT)
Industry: Real Estate Investment Trusts (172 Tracked Issuers)Across 1097 tracked Financials securities in the Roarable RQD universe, Medical Properties Trust Inc. (MPT) ranks #922 by composite RQD confidence (39/100, grade D-) and #511 by equity capitalization ($1.30B). Within this direct 5-issuer industry benchmark cohort, ALX leads on earnings valuation at 45.1x trailing P/E, while ALX leads on capital efficiency and profitability with 25.9% ROIC and — gross margin. ALX currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with MPT at 39/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MPT
ACTIVE
Medical Properties Trust Inc. | D- | 39/100 | — | — | -6.0% | -7.34% | $1.30B | Benchmark Subject |
| UMH UMH Properties Inc. | D | 49/100 | — | — | 0.7% | -3.40% | $1.30B | /umh-vs-mpt → |
| ALX Alexander's Inc. | C | 64/100 | 45.1x | — | 25.9% | -4.30% | $1.28B | /alx-vs-mpt → |
| AAT American Assets Trust Inc. | D+ | 57/100 | — | — | 11.3% | -0.73% | $1.34B | /aat-vs-mpt → |
| UNIT Uniti Group Inc. | E | 30/100 | — | — | 2.1% | +2.43% | $1.20B | /unit-vs-mpt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001287865 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Medical Properties Trust Inc. (MPT) reported GAAP revenue of $972.0M (-2.4% vs. FY2024 revenue of $995.5M , and +11.5% cumulative change since FY2023) , GAAP net income of -$277.0M, operating cash flow of $230.8M, and free cash flow of $230.8M (-6.0% YoY). On the balance sheet, MPT closed FY2025 with $15.00B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $972.0M | -$277.0M | $230.8M | $230.8M | $15.00B | — |
| FY2024 (FY) | 2024-12-31 | $995.5M | -$2.41B | $245.5M | $245.5M | $14.29B | — |
| FY2023 (FY) | 2023-12-31 | $871.8M | -$556.5M | $505.8M | $505.8M | — | — |
3. MPT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Medical Properties Trust Inc. (NYSE: MPT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $2.02 (-7.34% 1D, market cap $1.30B). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, MPT ranks #922 in composite RQD confidence.
How does MPT compare to UMH and ALX in the Financials sector?
Within the Financials sector (Real Estate Investment Trusts), MPT carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -6.0%. By comparison, UMH (UMH Properties Inc.) holds a D grade (49/100 RQD, P/E N/A, ROIC 0.7%, cap $1.30B) and ALX (Alexander's Inc.) posts a C grade (64/100 RQD, P/E 45.1x, ROIC 25.9%, cap $1.28B). Among the 5-stock peer group, ALX leads on earnings multiple (45.1x) while ALX leads on capital efficiency (25.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MPT?
Per MPT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001287865), Medical Properties Trust Inc. generated $972.0M in revenue (-2.4% YoY), -$277.0M in net income, and $230.8M in free cash flow against $15.00B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MPT trading relative to its 50-day, 200-day, and 52-week technical levels?
MPT last traded at $2.02 (-7.34% on volume of 42,685,428 shares), positioning the stock -38.97% below its 50-day simple moving average ($3.31) and -55.31% below its 200-day simple moving average ($4.52). Across its 52-week range of $2.06 to $6.47, MPT sits at the 0.0% percentile with a 14-day RSI of 25.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.77 to $2.27).
MPT — Medical Properties Trust Inc.: What the Facts Mean to a Prospective Investor
1. Roarable Rating Brief: What This Means to a Prospective Investor
Medical Properties Trust Inc. (MPT) earns a live Roarable RQD composite score of 39/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $2.02 (-7.34% 1D, market capitalization $1.30B).
- Fundamental Cash Engine (7/20): Anchored by return on invested capital (ROIC) of -6.0%, gross margin of —, operating margin of —, and free cash flow yield of 15.84%.
- Whale 13F & Options Flow (5/20) + Insider Conviction (9/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (7/20) + Forensic Balance Sheet (11/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Medical Properties Trust Inc. Is listed on the NYSE and classified in the Financials sector, Real Estate Investment Trusts industry. Net margin is reported at -28.5% and FCF yield at 15.84%.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Medical Properties Trust Inc. (MPT) reported $972.0M in annual revenue (up from $995.5M in FY2024, -2.4% YoY) and -$277.0M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($871.8M revenue, -$556.5M net income) through FY2025, MPT scaled operating cash flow to $230.8M and free cash flow to $230.8M, backed by $15.00B in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D- • RQD 39/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of 15.84% and institutional whale pillar of 5/20. With Fundamental Cash Engine at 7/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $2.06 – $6.47 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
No upstream or downstream supply-chain dependencies are reported, and the links array is empty. Sector correlation data beyond the Financials / Real Estate Investment Trusts classification is — The main second-order observation an investor should track is that the stock's reported beta of 1.0 and its sector classification mean its price path is linked to broader REIT and market conditions, though the source does not quantify those correlations.
- Key Question #1: Can MPT sustain or expand its — operating margin and -6.0% ROIC against Real Estate Investment Trusts peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $972.0M and free cash flow of $230.8M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is MPT's equity valuation to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
MPT Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Medical Properties Trust Inc. (MPT) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Investing.com report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
Quiver Quantitative report covering Medical Properties Trust Inc. (MPT) market action, institutional positioning, and fundamental catalysts.
MPT Bull vs. Bear Conversation Board — What's Your Call at $2.02?
The reported 15.84% FCF yield at a $2.44 share price suggests cash generation is high relative to market value, a potential upside driv
The street is overcomplicating Medical Properties Trust Inc. (MPT). The reported 15.84% FCF yield at a $2.44 share price suggests cash generation is high relative to market value, a potential upside driver if it proves durable.. With an RQD score of 39/100 (D-) and Forensic Balance Sheet at 11/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $2.43.
@MidwestValue Agree on the RQD 39/100 quality, though with 1.0 beta I'm scaling in with half-size at $2.25 and keeping dry powder in case we test $2.09.
Negative ROIC of -6%, a -28.5% net margin, and an institutional-flow pillar score of 4/20 indicate weak capital returns and limited sus
Careful chasing MPT at $2.25. Negative ROIC of -6%, a -28.5% net margin, and an institutional-flow pillar score of 4/20 indicate weak capital returns and limited sustained institutional conviction.. Gross margin is 0.0%, but operating margin is 0.0%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $1.69 on multiple compression.